Numerous serum biomarkers for lymphomas were proposed for their clinical value such as soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) [6]; soluble Fas/CD95/APO-1 [7]; soluble tumor necrosis factor receptor 2 (sTNF-R2) [8]; soluble interleukin-2 receptor (sIL-2R) [9]; nm23-H1 protein [10]; and soluble CD44 [11]. The gene discussed is FAS; the disease is lymphoma.